A replication-incompetent PB2-knockout influenza A virus vaccine vector

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Influenza virus infection poses a significant global health threat.
• Vaccination remains the primary strategy for influenza prevention.
• Developing safe and effective influenza vaccines is crucial.

Purpose of the Study:

• To evaluate the efficacy of a replication-incompetent PB2-knockout (PB2-KO) influenza virus as a vaccine candidate.
• To assess the immunogenicity and protective potential of the PB2-KO virus in a murine model.
• To explore the feasibility of the PB2-KO virus as a platform for multivalent vaccines.

Main Methods:

• Development of a replication-incompetent influenza virus (PB2-KO) with a reporter gene.
• Immunization of mice with the PB2-KO virus and a conventional inactivated vaccine.
• Assessment of antibody levels (IgG and IgA) in sera and mucosal fluids.
• Challenge studies with lethal doses of influenza virus.
• Detection of antibodies against the reporter protein.

Main Results:

• PB2-KO virus replicated effectively in PB2-expressing cells, indicating potential safety.
• Immunization with PB2-KO virus induced higher levels of influenza-specific IgG and IgA antibodies compared to inactivated vaccine.
• All mice immunized with PB2-KO virus survived lethal influenza challenge.
• Antibodies against the reporter protein were generated in immunized mice.

Conclusions:

• The PB2-KO influenza virus is a safe and effective vaccine candidate in a murine model.
• PB2-KO virus elicits superior humoral immune responses compared to conventional inactivated vaccines.
• The PB2-KO virus platform holds potential for developing multivalent vaccines against influenza and other pathogens.